New funding boost for the Great Ormond Street Hospital Clinical Research Facility
28 Feb 2022, 1 p.m.
The National Institute for Health Research (NIHR) has announced that the Great Ormond Street Hospital (GOSH) Clinical Research Facility (CRF) is one of 28 centres from across the country to receive 5-years of funding to deliver early stage clinical research.
Our Clinical Research Facility at GOSH (CRF)
The NIHR GOSH CRF provides specialist day care accommodation for children and young people taking part in clinical research studies, as well overnight stays where required. This state of the art, purpose-built facility is available to all GOSH/ICH staff undertaking clinical research, in particular early phase and experimental medicine trials.
The NIHR Clinical Research Facility at GOSH is an integral part of our Research Hospital.
We deliver research that transforms the lives of so many children with rare and complex diseases and our Clinical Research Facility (CRF) is instrumental in embedding this across the wider hospital, for direct impact on patient care.
We look forward to growing our facility and working with other stakeholders across the life sciences industry to deliver an even stronger portfolio of innovative trials, with an even greater demonstrable impact for our patients and their families.
Between 2020-21, staff at the NIHR GOSH CRF managed:
- 702 on site patient visits
- over 2000 remote visits.
During this time the CRF supported 34 Phase I and II clinical studies, facilitating the life-changing research taking place across our GOSH Research Hospital.
Continuing our incredible research at GOSH
This new 5-year funding for our NIHR GOSH CRF will enable us to develop and strengthen our early translational and experimental medicine research.
We are delighted that NIHR have demonstrated their continued support of our ambitions. The quality and breadth of the early translational and experimental medicine research, both here and in collaboration with our strategic partners has been recognised as exceptional, and we are very proud of this team effort.
NIHR CRFs also have a remit to support skills and workforce development, to grow expertise in delivering early translational and experimental medicine studies. This remit covers both people who lead and design trials and people in the essential supporting roles that deliver the research on the ground.
This funding will allow us to continue to build both the infrastructure and incredible team that are a vital part of our Research Hospital.
Since our Clinical Research Facility was established 12 years ago, we have continued to grow and expand our research portfolio.
Our research delivery workforce has developed substantially during this time and we have created opportunities for our staff, such that this is a fantastic place to work. Our wonderful teams, both based in the CRF and across the hospital share our vision for research at GOSH, which they run smoothly and efficiently. We are incredibly proud of our team and look forward to the next five years of research.
New director of UCL Great Ormond Street Institute of Child Health
The UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have announced that Professor Helen Cross, an Honorary Consultant in Paediatric Neurology at GOSH, will take up the post of Director of the institute from 1 September 2022.
Can we use artificial intelligence (AI) to better diagnose fractures?
Dr Susan Shelmerdine, Consultant Paediatric Radiologist at Great Ormond Street Hospital (GOSH) discusses her research into using artificial intelligence (AI) to identify fractures in children.
People power being used to analyse eye research at GOSH
Months of work will be completed in a few days as members of the public help to examine high-resolution images of the potentially blinding eye condition, uveitis, as part of a project working across GOSH, UCL GOS ICH and Moorfields Eye Hospital.
What do young people want from Artificial Intelligence in healthcare?
Artificial intelligence in healthcare is a rapidly growing field. Children and teenagers often have insightful questions about AI, but are rarely involved in the development of new technologies. See how we're changing this...